Mahmoud Elkazzaz

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Can Intranasal insulin and Cholinergic agonist improve PostCovid-19 Cognition Impairment?
  Advanced Pharmaceutical Bulletin 2023 DOI: 10.34172/apb.2024.017
  +Save
• Inhibition of colorectal cancer targets IL-6, CTLA-4, & B7-2 by Tislelizumab: molecular docking, dynamics, & STRING protein-protein network analysis
  Informatics in Medicine Unlocked 2023 DOI: 10.1016/j.imu.2023.101323
  +Save
• Pregnant and Breastfeeding Mothers Who Have Received the ChAdOx1 AstraZeneca COVID-19 Vaccine May Have Infants with an Increased Risk of Zinc Insufficiency and SCID Disease
  Advanced Pharmaceutical Bulletin 2023 DOI: 10.34172/apb.2023.024
  +Save
• In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19
  Vaccines 2022 DOI: 10.3390/vaccines10091500
  +Save
• Dexamethasone is a gold weapon for immunomodulation in severe COVID-19 but has no effect on endocrine interleukin 6 and sex-linked response the problem – In silico study
  2021 DOI: 10.14293/S2199-1006.1.SOR-.PPO5NHG.v2
  +Save
• Dexamethasone is a gold weapon for immunomodulation in severe COVID-19 but has no effect on endocrine interleukin 6 and sex-linked response the problem – In silico study
  2021 DOI: 10.14293/S2199-1006.1.SOR-.PPO5NHG.v1
  +Save